Your browser doesn't support javascript.
loading
Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
Buqaileh, Raghad; Saternos, Hannah; Ley, Sidney; Aranda, Arianna; Forero, Kathleen; AbouAlaiwi, Wissam A.
Afiliação
  • Buqaileh R; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
  • Saternos H; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
  • Ley S; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
  • Aranda A; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
  • Forero K; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
  • AbouAlaiwi WA; Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio.
Physiol Genomics ; 53(6): 249-258, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33855870

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cílios / Internalização do Vírus / Injúria Renal Aguda / SARS-CoV-2 / COVID-19 / Rim Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cílios / Internalização do Vírus / Injúria Renal Aguda / SARS-CoV-2 / COVID-19 / Rim Idioma: En Ano de publicação: 2021 Tipo de documento: Article